Results 181 to 190 of about 16,205 (225)
Some of the next articles are maybe not open access.

[Acellular pertussis vaccine].

Wiener medizinische Wochenschrift (1946), 1991
Acellular pertussis vaccines contain antigen components of B. pertussis, usually lymphocytosis promoting factor (LPF) which is also called pertussis-toxin (PT) or pertussigen, filamentous hemagglutinin (FH) and, eventually, agglutinogens 2 and 3. Acellular vaccines are being used in Japan since 1981.
G, Wiedermann, F, Ambrosch, H, Vanura
openaire   +1 more source

[Acellular pertussis vaccines].

Immunitat und Infektion, 1993
Each vaccine is normally rated according to its efficacy and to the frequency and severity of unwanted side effects. The efficacy of whole-cell pertussis vaccines is beyond doubt, its frequent side effects, however, stimulated research into less reactogenic acellular vaccines.
H, Finger, C H, Wirsing von König
openaire   +1 more source

Potency testing of acellular pertussis vaccines

Vaccine, 1992
The laboratory assessment of the potential of acellular pertussis vaccines to protect against human disease is a major problem. The mouse intracerebral challenge test, which is the accepted potency assay for whole cell pertussis vaccines, is not suitable for testing acellular vaccines, and more recently developed murine respiratory infection assays ...
A, Robinson, S G, Funnell
openaire   +2 more sources

The Efficacy of Acellular Pertussis Vaccine

JAMA: The Journal of the American Medical Association, 1989
To the Editor.— Reporting from a workshop at the National Institutes of Health, Bethesda, Md, 1 Mr Marwick stated that "the large Swedish field trial of two acellular pertussis vaccines 2 has not shown levels of efficacy high enough to make either vaccine a likely candidatefor immediate licensure in the United States." We can now report efficacy data ...
P, Olin, J, Storsaeter, V, Romanus
openaire   +2 more sources

Whole-Cell and Acellular Pertussis Vaccines

Annals of Pharmacotherapy, 1994
OBJECTIVE: To provide a review of pertussis vaccines, including information on efficacy, adverse reactions, and antibody production following administration of both whole-cell and acellular pertussis vaccines. DATA SOURCES: A MEDLINE search and extensive review of journals was conducted to identify the information for this review.
S M, Wintermeyer   +2 more
openaire   +2 more sources

Acellular pertussis vaccines

Pediatric Infectious Disease Journal, 1987
A R, Hinman, I M, Onorato
openaire   +2 more sources

Acellular Vaccines and Resurgence of Pertussis

JAMA, 2012
PERTUSSIS IS A HIGHLY CONTAGIOUS, VACCINEpreventable disease for which a whole-cell vaccine (killed bacteria), in combination with toxoids against diphtheria and tetanus (DTwP), was introduced for immunization of children in the United States in the 1940s. With the eventual widespread use of DTwP vaccine, the national annual incidence of reported cases
openaire   +2 more sources

ACELLULAR PERTUSSIS VACCINES

2016
Pertussis is a dangerous infectious disease that is well controlled world-wide by widespread immunization. The major cause of the decline in the morbidity and mortality of the disease is the intensive World Health Organization's Expanded Program on Immunization.
openaire   +1 more source

[Acellular anti-pertussis vaccine].

Bulletin de la Societe de pathologie exotique (1990), 1992
Since several years, pertussis has increased especially in non-immunized young infants under 6 months of age, in countries where pertussis-immunization is in widespread use. The whole-cellular pertussis vaccine so far used in these countries is not well tolerated, has been indicted in adverse neurological complications, and offers significant but ...
P, Bégué, E, Grimpel, S, Baron
openaire   +1 more source

Pertussis vaccines: acellular versus whole‐cell

Medical Journal of Australia, 1996
Acellular pertussis vaccines containing purified Bordetella pertussis antigens have now been extensively field tested. They produce a significantly lower rate of reactions than whole-cell vaccines and their efficacy is either comparable or superior.
openaire   +2 more sources

Home - About - Disclaimer - Privacy